About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Cardiovascular Pharmacology: Open Access
›
top-articles
Cardiovascular Pharmacology: Open Access
0.1
(top 100%)
impact factor
196
(top 50%)
papers
223
(top 50%)
citations
6
(top 50%)
h
-index
0.2
(top 100%)
extended IF
200
all documents
236
doc citations
11
(top 50%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
The Fractal-like Complexity of Heart Rate Variability beyond Neurotransmitters and Autonomic Receptors: Signaling Intrinsic to Sinoatrial Node Pacemaker Cells
Cardiovascular Pharmacology: Open Access
2013
26
2
CYP-450 Epoxygenase Derived Epoxyeicosatrienoic Acid Contribute To Reversal of Heart Failure in Obesity-Induced Diabetic Cardiomyopathy via PGC-1α Activation
Cardiovascular Pharmacology: Open Access
2018
24
3
Cardio-Ankle Vascular Index (CAVI) and its Potential Clinical Implications for Cardiovascular Disease
Cardiovascular Pharmacology: Open Access
2013
10
4
AMP-Activated Protein Kinase Signalling in Cancer and Cardiac Hypertrophy
Cardiovascular Pharmacology: Open Access
2015
9
5
Reducing Cardiac Fibrosis: Na/K-ATPase Signaling Complex as a Novel Target
Cardiovascular Pharmacology: Open Access
2017
7
6
Sodium Glucose Transporter 2 (SGLT2) Inhibition does not Protect the Myocardium from Acute Ischemic Reperfusion Injury but Modulates Post- Ischemic Mitochondrial Function
Cardiovascular Pharmacology: Open Access
2017
7
7
A Study of the Effect of Isoproterenol on Red Blood Cell Concentrations of Adenine Nucleotides in a Freely Moving Rat Model In Vivo*
Cardiovascular Pharmacology: Open Access
2013
6
8
A Novel ASK Inhibitor AGI-1067 Inhibits TLR-4-Mediated Activation of ASK1 by Preventing Dissociation of Thioredoxin from ASK1
Cardiovascular Pharmacology: Open Access
2015
6
9
Switching of Ticagrelor to Clopidogrel at 3 Months in Patients Treated for Acute Care Syndrome; Single Centre Experience
Cardiovascular Pharmacology: Open Access
2016
6
10
Resolution of Left Ventricular Thrombus after Dabigatran Therapy in Two Patients with Old Anteroseptal Myocardial Infarction
Cardiovascular Pharmacology: Open Access
2015
6
11
The Probability of Inconstancy in Assessment of Cardiac Function Post- Myocardial Infarction in Mice
Cardiovascular Pharmacology: Open Access
2016
6
12
ATP Metabolism as Biomarker Target for Cardiovascular Protection
Cardiovascular Pharmacology: Open Access
2013
6
13
Acenocoumarol in Thromoembolic Disorders
Cardiovascular Pharmacology: Open Access
2015
5
14
Measuring Platelet Reactivity after Clopidogrel-Has it Reached the End of the Road?
Cardiovascular Pharmacology: Open Access
2013
4
15
Drugs for the Prevention and Treatment of Cardiac Allograft Vasculopathy
Cardiovascular Pharmacology: Open Access
2014
4
16
Current and Potential Antiarrhythmic Drugs Targeting Voltage-Gated Cardiac Ion Channels
Cardiovascular Pharmacology: Open Access
2015
4
17
Impact of the New P2Y12 Receptor Inhibitors on Mortality in STElevation Myocardial Infarction Patients with Cardiogenic Shock and / or After Cardiopulmonary Resuscitation Undergoing Percutaneous Coronary Intervention
Cardiovascular Pharmacology: Open Access
2016
4
18
Effects of JNJ-54452840, an Anti-β1 Receptor Antibody Cyclopeptide in Heart Failure Patients: A Randomized, Double-blind, Parallel-group, Phase-2 Pilot Study
Cardiovascular Pharmacology: Open Access
2016
4
19
Re-evaluation of Bleeding Events in the Japanese PRASFIT-Elective and PRASFIT-ACS Clinical Trials using the Bleeding Academic Research Consortium Criteria
Cardiovascular Pharmacology: Open Access
2015
3
20
Recombinant Human Elastase Treatment of Cephalic Veins
Cardiovascular Pharmacology: Open Access
2016
3
21
From Arctic to Antarctic: Is There any Remaining Role for Platelet Function Testing to Tailor Therapy after Coronary Stent Implantation?
Cardiovascular Pharmacology: Open Access
2016
3
22
Supraphysiological Testosterone Levels Shorten the QT Interval but do Not Alter Total Anatomic Myocardial Infarct Size in Rabbits with Acute Myocardial Infarction
Cardiovascular Pharmacology: Open Access
2014
3
23
Pharmacological Inhibition of Phosholipase A2: Results from Phase 3 Clinical Trials with Darapladib and Varespladib in Patients with Cardiovascular Disease
Cardiovascular Pharmacology: Open Access
2015
3
24
Effect of Vildagliptin, Compared to Sitagliptin, on the Onset of Hyperglycemia-Induced Metabolic Memory in Human Umbilical Vein Endothelial Cells
Cardiovascular Pharmacology: Open Access
2017
3
25
Mechanism of Gender-Related Differences in Vascular Function
Cardiovascular Pharmacology: Open Access
2018
3
26
Exploring Future Cardiovascular Medicine: Heart Precursors Directed From Human Embryonic Stem Cells For Myocardium Regeneration
Cardiovascular Pharmacology: Open Access
2013
3
27
Reviving Cell-Based Regenerative Medicine for Heart Reconstitution with Efficiency in Deriving Cardiac Elements from Pluripotent Human Embryonic Stem Cells
Cardiovascular Pharmacology: Open Access
2013
3
28
Preventing Recurrences: Classic and Modern Antiarrhythmic Drugs in Atrial Fibrillation
Cardiovascular Pharmacology: Open Access
2014
2
29
Relation of Cholesterol Level to Dietary Fat Intake in Patients of Ischemic Heart Disease
Cardiovascular Pharmacology: Open Access
2015
2
30
Trials Evaluating Ticagrelor in Cardiovascular Disease: Will It Reign Supreme in the Anti-Platelet World?
Cardiovascular Pharmacology: Open Access
2017
2
31
Down Syndrome with Unbalanced Complete Atrioventricular Septal Defect and Truncus Arteriosus
Cardiovascular Pharmacology: Open Access
2017
2
32
Anti-Thrombotic Drug Problems
Cardiovascular Pharmacology: Open Access
2018
2
33
Transhepatic Approach for Device Closure of Secundum Atrial Septal Defect in Patient with Interrupted Inferior Vena Cava
Cardiovascular Pharmacology: Open Access
2014
2
34
Acute Myocardial Injury: A Perspective on Lethal Reperfusion Injury
Cardiovascular Pharmacology: Open Access
2017
2
35
Potential of Monocyte Count for the Assessment of Cardiovascular Disease
Cardiovascular Pharmacology: Open Access
2017
2
36
MicroRNA Therapeutics for Cardiac Disease
Cardiovascular Pharmacology: Open Access
2013
2
37
Role of Bone Morphogenetic Protein Type II Receptor Signaling in Pulmonary Arterial Hypertension
Cardiovascular Pharmacology: Open Access
2013
2
38
Coenzyme Q10 for Cardiovascular Prevention
Cardiovascular Pharmacology: Open Access
2014
2
39
Application of Intima Media Thickness Measurement and Omics in Intrauterine Growth Restriction Disease
Cardiovascular Pharmacology: Open Access
2014
2
40
Dexmedetomidine: The Anesthetic as an Antiarrythmic
Cardiovascular Pharmacology: Open Access
2015
2
41
Endothelial Dysfunction Induced by Chronic Psychological Stress: A Risk Factor for Atherosclerosis
Cardiovascular Pharmacology: Open Access
2015
2
42
Apocynin Exerts Dose-Dependent Cardioprotective Effects by Attenuating Reactive Oxygen Species in Ischemia/Reperfusion
Cardiovascular Pharmacology: Open Access
2016
2
43
Cardio-Oncology: A Tale of Two Diseases
Cardiovascular Pharmacology: Open Access
2017
2
44
Hypertrophic and Inflammatory Markers in Isoproterenol-Induced CardiacHypertrophy and its Pharmacological Correction
Cardiovascular Pharmacology: Open Access
2017
2
45
Complementary Effect of Exercise in Cardiovascular Medicine
Cardiovascular Pharmacology: Open Access
2013
1
46
Stress as a Risk Factor for Cardiovascular Events
Cardiovascular Pharmacology: Open Access
2015
1
47
Clinical Care for the Patient with Heart Failure: A Nursing Care Perspective
Cardiovascular Pharmacology: Open Access
2015
1
48
Pharmacotherapy in the Cardiac Catheterization Laboratory
Cardiovascular Pharmacology: Open Access
2015
1
49
Early Subclinical Biomarkers in Onco-Cardiology to Prevent Cardiac Death
Cardiovascular Pharmacology: Open Access
2015
1
50
Molecular Basis for Mercury-Induced Alteration in Endothelial Function: NO and its Modulators
Cardiovascular Pharmacology: Open Access
2015
1
site/software ©
exaly
; All materials licenced under
CC by-SA
.